Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.38 |
| ▸ | CCKBR | P32239 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tenidap SCHEMBL3751878 | 1.00 | MEN1 (0.42) | MEN1KMT2AHTTCYP1A2CYP2C9 | |
| Tenidap SCHEMBL3751880 | 1.00 | MEN1 (0.42) | MEN1KMT2AHTTCYP1A2CYP2C9 | |
| Tenidap SCHEMBL30597938 | 0.86 | KMT2A (0.41) | MEN1KMT2AHTTCYP1A2CYP2C9 | |
| Tenidap SCHEMBL43098 | 0.86 | KMT2A (0.41) | MEN1KMT2AHTTCYP1A2CYP2C9 | |
| Tenidap SCHEMBL9216494 | 0.85 | ALDH1A1 (0.33) | HTTNPSR1ALDH1A1HSP90AA1 | |
| SCHEMBL9215467 | 0.84 | ALDH1A1 (0.36) | MEN1KMT2AHTTCYP1A2CYP2C9 | |
| SCHEMBL8816115 | 0.84 | CHEK1 (0.41) | KMT2AKDM4EALDH1A1RXFP1 | |
| SCHEMBL8816112 | 0.84 | CHEK1 (0.41) | KMT2AKDM4EALDH1A1RXFP1 | |
| SCHEMBL3676246 | 0.83 | ALDH1A1 (0.33) | HTTNPSR1ALDH1A1HSP90AA1 | |
| Ilonidap SCHEMBL42518 | 0.83 | ALDH1A1 (0.35) | MEN1KMT2AHTTCYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17044 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| US-12297294-B2 | Cortistatin analogues for the treatment of inflammatory and/or immune diseases | BCN PEPTIDES, S.A. (ES) | 2025-05-13 | — | — | US | claimed |
| US-20250041208-A1 | NEW INJECTABLE COMBINATION FORMULATION | NANEXA AB (SE) | 2025-02-06 | — | — | US | claimed |
| CN-112770764-B | Methods of treating infections using bacteria | 因达普特斯治疗有限公司 | 2024-12-03 | — | — | CN | claimed |
| EP-4444277-A1 | NEW INJECTABLE COMBINATION FORMULATION | Nanexa AB (SE) | 2024-10-16 | — | — | EP | claimed |
| CN-118647367-A | Novel injectable combination formulations | 南爱克萨股份公司 | 2024-09-13 | — | — | CN | claimed |
| CN-118512401-A | Lipid vesicle compositions with permeation enhancers | 迪迪艾斯研究公司 | 2024-08-20 | — | — | CN | claimed |
| CN-115175667-B | Lipid vesicle compositions with permeation enhancers | 迪迪艾斯研究公司 | 2024-06-04 | — | — | CN | claimed |
| EP-4335413-A2 | PROSTHETIC TISSUE VALVES | Cormatrix Cardiovascular, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| EP-3856213-B1 | METHODS OF TREATMENT OF INFECTIONS USING BACTERIA | INDAPTUS THERAPEUTICS INC (US) | 2024-03-06 | — | — | EP | claimed |
| US-5308839-A | Nonsteroid antiinflammatory agents | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1994-05-03 | — | — | US | claimed |
| EP-0586020-A1 | Tetracyclines alone or in combination with NSAID for treating tissue destruction | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1994-03-09 | — | — | EP | claimed |
| WO-1994000130-A1 | COMPOSITIONS FOR THE TREATMENT OF ARTHRITIS CONTAINING PHOSPHONATES AND NSAIDS | PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) | 1994-01-06 | — | — | WO | claimed |
| WO-1993013758-A1 | PREPARATION OF TABLETS OF INCREASED STRENGTH | PFIZER INC. (US) | 1993-07-22 | — | — | WO | claimed |
| EP-0498588-A1 | Use of tenidap to reduce total serum cholesterol, LDL cholesterol and triglycerides | PFIZER INC. (US) | 1992-08-12 | — | — | EP | claimed |
| US-5122534-A | USE OF TENIDAP TO REDUCE TOTAL SERUM CHOLESTEROL, LDL CHOLESTEROL AND TRIGLYCERIDES | PFIZER INC. (US) | 1992-06-16 | — | — | US | claimed |
| EP-0448261-A2 | Tenidap as an inhibitor of the release of elastase by neutrophils | PFIZER INC. (US) | 1991-09-25 | — | — | EP | claimed |
| EP-0448253-A2 | Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase | PFIZER INC. (US) | 1991-09-25 | — | — | EP | claimed |
| US-5008283-A | Antiinflammatory agents; vision, skin and bone disorders | PFIZER INC. (US) | 1991-04-16 | — | — | US | claimed |
| US-5006547-A | Tenidap as an inhibitor of the release of elastase by neutrophils | PFIZER INC. (US) | 1991-04-09 | — | — | US | claimed |